Less Invasive Surfactant Administration in Extremely Preterm Infants: Impact on Mortality and Morbidity
Authors:
- Katrin Klebermass-SchrehofKKKatrin Klebermass-Schrehof
- Martin WaldMWMartin Wald
- Jens SchwindtJSJens Schwindt
- Agnes GrillAGAgnes Grill
- Andrea-Romana PrusaAPAndrea-Romana Prusa
- Nadja HaidenNadja Haiden
- Michael HaydeMHMichael Hayde
- Thomas WaldhoerThomas Waldhoer
- Renate FuikoRFRenate Fuiko
- Angelika BergerABAngelika Berger
- 22 February 2013
- journal article
- research article
- Published by S. Karger AG in Neonatology
- Vol. 103 (4) , 252-258
Abstract
Background: A new mode of surfactant administration without intubation - less invasive surfactant administration (LISA) - has recently been described for premature infants. Objective: We report single-center outcome data of extremely premature infants who have been managed by LISA in our department. Mortality and morbidity rates of the cohort were compared to historical controls from our own center and to data of the Vermont-Oxford Neonatal Network (VONN). Patients and Methods: All infants born at 23-27 weeks' gestational age during 01/2009 and 06/2011 (n = 224) were managed by LISA and included in the study group. Results: LISA was tolerated by 94% of all infants. 68% of infants stayed on continuous positive airway pressure on day 3. The rate of mechanical ventilation was 35% within the first week and 59% during the entire hospital stay. Compared to historical controls, we found significantly higher survival rates (75.8 vs. 64.1%) and significantly less intraventricular hemorrhage (IVH) (28.1 vs. 45.9%), severe IVH (13.1 vs. 23.9%) and cystic periventricular leukomalacia (1.2 vs. 5.6%); only persistent ductus arteriousus (PDA) (74.7 vs. 52.6%) and retinopathy of prematurity (ROP) (40.5 vs. 21.1%) occurred significantly more often. Compared to VONN data, we found significantly less chronic lung disease (20.6 vs. 46.4%), severe cerebral lesions (IVH 3/4 + cystic PVL; 9.4 vs. 16.1%) and ROP (all grades) (40.5 vs. 56.5%); only PDA (74.7 vs. 63.1%) and severe ROP (> grade 2) (24.1 vs. 14.1%) occurred significantly more often in our cohort. Conclusion: Surfactant can be effectively and safely delivered via LISA and this is associated with low rates of mechanical ventilation and various adverse outcomes in extremely premature infants.Keywords
This publication has 22 references indexed in Scilit:
- Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trialThe Lancet, 2011
- Preliminary evaluation of a new technique of minimally invasive surfactant therapyArchives of Disease in Childhood - Fetal and Neonatal Edition, 2010
- An Open Label, Pilot Study of Aerosurf ® Combined with nCPAP to Prevent RDS in Preterm NeonatesJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Early CPAP versus Surfactant in Extremely Preterm InfantsNew England Journal of Medicine, 2010
- Early surfactant in spontaneously breathing with nCPAP in ELBW infants – a single centre four year experienceActa Paediatrica, 2008
- Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndromeCochrane Database of Systematic Reviews, 2007
- Proposed definition and classification of cerebral palsy, April 2005Developmental Medicine & Child Neurology, 2007
- Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age ≤27 weeks)Pediatric Anesthesia, 2006
- Laryngeal Mask Airway Used as a Delivery Conduit for the Administration of Surfactant to Preterm Infants with Respiratory Distress SyndromeNeonatology, 2005
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978